Cardiac magnetic resonance (CMR) T1 mapping has been used to characterize myocardial diffuse fibrosis.
T1 mapping has been proposed as potentially valuable in the quantitative assessment of diffuse myocardial fibrosis, but no studies to date have systematically evaluated its role in the differentiation of healthy myocardium from diffuse disease in a clinical setting.
.
